According to a report by SNS Insider, the global nuclear medicine market reached a valuation of USD 9.24 billion in 2022 and is projected to reach USD 24.20 billion by 2030, with a compound annual growth rate (CAGR) of 12.8% from 2023 to 2030. The market is experiencing significant growth due to factors such as the increasing prevalence of chronic diseases, advancements in imaging equipment and radiopharmaceutical development, and the growing aging population. Some of the key players in the market include Advanced Accelerators Applications, Bayer, Curium, Bracco Imaging, Cardinal Health, GE Healthcare, and Medtronic plc. North America, particularly the United States, leads the market, followed by Europe and the Asia-Pacific region.
Wed, 13 Dec 2023 14:03:11 GMT | GlobeNewswire